A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

NCT06069726 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Duke University